Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicentre Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel in Patients With Rheumatoid Arthritis (RA) and Axial Spondyloarthritis (axSpA) - The BENEFIT Study

Next Previous
X
Search
Trial Profile

A Multicentre Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel in Patients With Rheumatoid Arthritis (RA) and Axial Spondyloarthritis (axSpA) - The BENEFIT Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Nov 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Etanercept (Primary)
  • Indications Ankylosing spondylitis; Axial spondyloarthritis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms BENEFIT
  • Sponsors Biogen

    • Most Recent Events

    • 30 Jun 2020 Results evaluating the effectiveness and safety of the etanercept biosimilar SB4 following transition from reference etanercept, published in the Clinical and Experimental Rheumatology.
    • 23 Jul 2019 According to an Biogen media release, data from this study was presented at the Annual European Congress of Rheumatology (EULAR 2019) in Madrid, Spain (June 12-15, 2019).
    • 18 Jun 2019 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top